Published Technical Disclosure Archive

Enhanced Vessel Flow Control Systems and Methods

Publication ID: 24-11857195_0006_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Vessel Flow Control Systems and Methods,” Published Technical Disclosure No. 24-11857195_0006_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857195_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,195.

Summary of the Inventive Concept

The present invention relates to improved systems and methods for controlling vessel flow rate and/or pressure, enhancing treatment outcomes for afflicted vessels and/or tissues. The inventive concept leverages real-time monitoring of vessel health and functional status to dynamically adjust the occlusion factor of flow control devices, ensuring personalized and optimized vessel treatment.

Background and Problem Solved

The original patent disclosed systems and methods for controlling vessel flow rate and/or pressure. However, these systems had limitations in terms of adjusting to changing vessel conditions and providing personalized treatment. The present invention addresses these limitations by integrating real-time monitoring and machine learning algorithms to optimize vessel flow control, resulting in more effective and efficient treatment.

Detailed Description of the Inventive Concept

The inventive concept comprises a flow control device with a dynamically adjustable occlusion factor, which is adjusted based on real-time data from an integrated sensor or external monitoring systems. The sensor data is used to optimize vessel treatment by predicting optimal flow control parameters. The system can also include a machine learning algorithm to personalize vessel flow control based on individual patient data. The method of enhancing vessel flow control involves receiving real-time data on vessel health and functional status and adjusting the flow control device accordingly.

Novelty and Inventive Step

The new claims introduce the concept of real-time monitoring and dynamic adjustment of the occlusion factor, which is not present in the original patent. This innovation enables personalized and optimized vessel treatment, addressing the limitations of the original systems and methods.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of sensors or monitoring systems, integrating the system with other medical devices, or using different machine learning algorithms. Variations could also include applying the inventive concept to different types of vessels or tissues.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and neurovascular treatment. The system could be marketed as a standalone device or integrated into existing medical systems, offering a competitive advantage in terms of personalized and optimized vessel treatment.

CPC Classifications

SectionClassGroup
A A61 A61B17/1204
A A61 A61B17/12027
A A61 A61B17/12031
A A61 A61B17/12036
A A61 A61B17/12045
A A61 A61B17/12109
A A61 A61B17/12136
A A61 A61B17/12177
A A61 A61F2/86
A A61 A61F2/90
A A61 A61B2017/00004
A A61 A61B2090/064
A A61 A61F2002/068
A A61 A61F2250/0031

Field of Art

Medical device engineering, specifically interventional medical devices for vessel flow control and treatment, focusing on minimally invasive techniques for managing vessel occlusion and hemodynamic parameters

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in interventional medical technologies, advanced sensor integration, and adaptive control systems for vascular interventions, typically holding a master's or doctoral degree with 3-5 years of specialized experience

Obviousness Rationale

A person having ordinary skill in the art would recognize that integrating real-time monitoring and dynamic adjustment capabilities into existing vessel flow control devices represents a predictable technological evolution. The source patent's fundamental flow control mechanism provides a clear technological foundation that a skilled practitioner would naturally extend through sensor integration and adaptive control strategies. The proposed variations represent incremental improvements that leverage known medical monitoring and control techniques to enhance existing vessel treatment technologies.

Obvious Combinations & Variations

Source Patent Element
Variable occlusion element with controllable internal volume and occlusion factor
PTD Variation
Adding real-time sensor monitoring to dynamically adjust occlusion factor based on vessel health data
Obviousness Reasoning
Integrating sensors for feedback control is a well-established technique in medical device design, representing a predictable application of known monitoring strategies to enhance existing flow control mechanisms
Source Patent Element
Method for controlling vessel flow rate through occlusion
PTD Variation
Implementing machine learning algorithms to personalize occlusion parameter optimization
Obviousness Reasoning
Applying machine learning to medical device control represents a standard approach for improving treatment personalization, using predictable computational techniques to enhance existing medical technologies
Source Patent Element
Balloon-based occlusion device with adjustable parameters
PTD Variation
Developing an integrated sensor system that provides continuous vessel health monitoring
Obviousness Reasoning
Incorporating diagnostic capabilities into therapeutic devices is a common design strategy in medical engineering, representing an obvious extension of existing flow control technologies
Source Patent Element
Percentage-based occlusion control (5-100 percent range)
PTD Variation
Dynamic real-time adjustment of occlusion percentage based on continuous physiological feedback
Obviousness Reasoning
Extending static percentage-based control to dynamic, responsive control represents a natural technological progression using standard control engineering principles
Source Patent Element
Vessel flow control method with feedback mechanisms
PTD Variation
Implementing predictive modeling for optimizing vessel treatment parameters
Obviousness Reasoning
Developing predictive models from historical medical data is a standard approach in medical technology, representing an obvious application of data analysis techniques to existing medical device frameworks
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857195 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed vessel flow control system variations obvious and predictable extensions of existing medical device technologies. The incremental improvements in sensor integration, adaptive control, and personalized treatment optimization represent standard engineering approaches that would be readily conceived by a skilled practitioner without requiring inventive insight beyond the existing technological landscape.

Original Patent Information

Patent NumberUS 11,857,195
TitleVessel flow control devices and methods